Thyrotropin Binding Inhibiting Antibody (TBIAb) in Graves’ Disease

To determine the nature of TBIAb in Graves’ disease, TBIAb was measured and correlated to various clinical, thyroid functional indices and thyroid autoantibodies. The incidence of TBIAb in untreated Graves’ patients, patients in treatment and those in remission was 70.9%, 53.1% and 19.2%, respective...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Won Yong, Choi, Hyang Hee, Chun, Hun Jae, Ahn, Il-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association of Internal Medicine 1988
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532134/
https://www.ncbi.nlm.nih.gov/pubmed/2908684
http://dx.doi.org/10.3904/kjim.1988.3.1.45

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532134/
https://www.ncbi.nlm.nih.gov/pubmed/2908684
http://dx.doi.org/10.3904/kjim.1988.3.1.45

Ejemplares similares